Named Lectures arrow_drop_down

Named Lectures

Annually the Renal Association awards three highly prestigious named lectures that are given at is annual conference, UK Kidney Week® (UKKW).

Award Process

A call for nominations and nomination form will be sent to the RA Members one year in advance, during UKKW.

Members are asked to submit nominations of 100 words, indicating:

  • the topic area and lecturer
  • why the lecturer is authoritative on the topic
  • the qualities the lecturer has – has the Member heard the individual speak before, etc.

Nominations will be reviewed by a balanced appointments panel that is representative of the membership in terms of gender, ethnicity, interests and other characteristics.

The Panel makes its recommendation based on the merit of each applicant and in line with the criteria for each named lecture. Final decisions will be based on:

  • range of topics over several years (balance of lab science, translational research, epidemiology, health services research, etc.)
  • balance of programme for the coming UKKW Programme including:
    • mix of international and national speakers
    • diversity – following the RA diversity policy

The decision is ratified by the Trustee Board.

Unsuccessful nominees may be re-submitted in future years.

Next Nomination Round

The 2019 nomination round is now closed. The next call for nominations for 2020 will open in June, 2019 during UK Kidney Week. Please contact the Secretariat for further information in the meantime renal@renal.org

The Osman Lecture

The Osman Lecture of the Renal Association was endowed by Mrs Ruth Osman, widow of Dr. Arnold Osman, who was a founding member and the first President of the Renal Association who died in 1972.

The Osman Lecture  is   given at   the Renal Association   Annual Conference. Applications are warmly encouraged from UK and international nephrologists and renal scientists and can cover any topic related to kidney disease.

Osman lectures

  • 1975 – David Baldwin (USA) – Post-streptococcal glomerulonephritis and the end stage kidney
  • 1977 – David Kerr (UK) – Renal bone disease: the effects of dialysis and transplantation
  • 1979 – Jonas Bergstrom (Sweden) – Uraemic toxicity
  • 1981 – Hugh de Wardener (UK) – Naturiuretic hormone
  • 1984 – Robert Schrier (USA) – The cell biology of ichaemia
  • 1985 – Netar Mallick (UK) – Sapient glomerulopathies, or how far since Ellis?
  • 1987 – Philip Hoedemaeker (Netherlands) – New developments in experimental glomerulonephritis
  • 1990 – Andrew Rees (UK) – Rapidly progressive glomerulonephritis: from pathogenesis to treatment
  • 1991-4 – No lecturers appointed
  • 1995 – Gerry Coles (UK) – CAPD – a critique
  • 1997 – Robert Lechler (UK) – Overcoming the obstacle to successful long-term transplantation
  • 1999 – Nick Hastie (UK) – Wilm’s tumour – a case of abnormal nephrogenesis: multiple roles for the Wilm’s tumour suppressor WT1
  • 2001 – Norbert Lamiere (Belgium) – Disaster nephrology
  • 2003 – Jeffrey Platt (USA) – New insights into autoimmunity
  • 2005 – No lecturers appointed
  • 2006 – Peter Mathieson (UK) – Focal segmental glomerulosclerosis
  • 2007 – No lecturers appointed
  • 2008 – Juergen Floege (Germany) – From cage to bedside: new approaches to the treatment of CKD patients
  • 2009 – Andy Rees (Austria) – Small vessel vasculitis – from humans to experimental models and back again
  • 2010 – David Salant (USA) – The antigenic target in membranous nephropathy
  • 2011 – Myles Wolf (USA) – Role of FGF23 in Adverse Clinical Outcomes in CKD
  • 2012 – Fiona Karet (UK) – Chasing Tails: Clinic to C-terminus
  • 2013 – John Feehally (UK) – Global Nephrology
  • 2014 – Caroline Savage (UK) – How can industry and academia collaborate to deliver clinical research?
  • 2015 – Robert Kleta (UK)  – Renal Fanconi syndromes
  • 2016 – Claire Sharpe (UK) – New therapeutic targets in renal fibrosis, how do we jump the barrier to clinical translation?
  • 2017 – Paul Brenchley (UK) – What is new in Membranous Nephropathy?
  • 2018 – No lecturers appointed

The Chandos Lecture

The Chandos Lecture of the Renal Association was established in 1976 with the support of the National Kidney Research Fund [NKRF],. The Chandos family have given great support to the renal community in this country over many years. The Honourable Anthony Lyttleton, the second Viscount Chandos, developed renal failure in the 1960s, and was treated by dialysis and subsequently received a renal transplant at Charing Cross Hospital under Professor Hugh de Wardener. Lord Chandos hosted the launch of NKRF (now Kidney Research UK) at Westminster in 1966, and until his death continued to use his considerable influence to promote the issues of renal disease and renal care in high places.

The Chandos  Lecture is  given at  the Renal Association  Annual Conference. Applications are warmly encouraged from UK and international nephrologists and renal scientists and can cover any topic related to kidney disease.

Chandos lectures

  • 1976 – Larry Earley (USA) – The development of the concept of control of sodium reabsorption by physical factors
  • 1978 – Charles Cochrane (USA) – Mediation of glomerular injury
  • 1980 – Barry Brenner (USA) – The physiological basis of glomerular filtration
  • 1982 – Michael Mauer (USA) – The glomerular mesangium in diabetic nephropathy
  • 1986 – Saulo Klahr (USA) – The effects of urinary obstruction
  • 1988 – Ramzi Cotran (USA) – Endothelial activation in vascular injury
  • 1991 – Herman Waldmann (UK) – Prospects for transplantation tolerance
  • 1992-5 – No lecturers appointed
  • 1996 – Marc de Broe (Belgium) – Recovery from injury to the kidney
  • 1998 – Stuart Shankland (USA) – The role of cell cycle proteins in glomerular disease
  • 2000 – Mark Pepys (UK) – Prognostic and pathogenetic significance of C-reactive protein
  • 2002 – Peter Ratcliffe (UK) – Oxygen sensing
  • 2004 – Ram Gokal (UK) – Peritoneal dialysis
  • 2006 – No lecturers appointed
  • 2007 – Steve Harper (UK) – How the glomerulus works in health and disease – or so you thought
  • 2008 – No lecturers appointed
  • 2009 – Dontscho Kerjaschki (Austria) – Podoplanin – from podocytes and beyond
  • 2010 – Rob Horne (UK) – Supporting behaviour changes in patients with chronic kidney disease
  • 2011 – Fred Finkelstein (USA) – Quality of life on dialysis: The Patients’ Perspective
  • 2012 – Gerry Appel (USA) – What have we learned about the treatment of Lupus Nephritis
  • 2013 – No lecturers appointed
  • 2014 – No lectures appointed
  • 2015 – Ken Farrington (UK) – End-of-life and palliative care in the dialysis setting
  • 2016 – Liz Lightstone (UK) – Pregnancy and Kidney Disease: the 3Ps
  • 2017 – Simon Davies (UK) – Can we control volume sufficiently in anuric patients?
  • 2018 – Menna Clatworthy (UK) – Life in the marshes – kidney environment shapes immune cell function

The de Wardener Lecture

The de Wardener lecture was established in 2004 in honour of Professor Hugh de Wardener (1915-2014), one of the UK’s most distinguished nephrologists and clinical scientists. He was President of both the Renal Association [1974-77] and the International Society of Nephrology [1969-72].

The first lecture was given by Professor de Wardener himself . From 2006 it became a regular feature of the Renal Association Annual Conference, and chosen lecturers  have a distinguished record in clinical research related to renal disease.

de Wardener lectures

  • 2004 – Hugh de Wardener (UK) – Plasma sodium and hypertension
  • 2005 – Graham MacGregor (UK) – Salt – Neptune’s gift?
  • 2006 – Bryan Williams (UK) – The hypertensive heart
  • 2007 – Pierre Ronco (France) – New insights into the pathophysiology of membranous nephropathy: a bench-to-bedside story
  • 2008 – Richard J Johnson (USA) – Uric acid, the metabolic syndrome and kidney disease
  • 2009 – Tim Goodship (UK) – Haemolytic Uraemic Syndrome
  • 2010 – Barry Freedman (USA) – New genetic insights in end-stage renal disease
  • 2011 – Hans Oberleithner (Germany)  – Sodium: Wolf in Sheep’s Clothing
  • 2012 – Peter Mathieson (UK) – Towards rational therapy for proteinuria
  • 2013 – Terry Cook (UK) – Conventional and molecular microscopy in renal transplant pathology
  • 2014 – Neil Turner (UK) – Alports and the structure of the glomerulus
  • 2015 – David Jayne (UK) –  B-cell targeting in ANCA-associated vasculitis
  • 2016 – Adrian Woolf (UK) – Kidney and urinary tract malformations: from the clinic to understanding molecular mechanisms and envisioning novel therapies
  • 2017 – David Wheeler (UK) – Sweetening the urine: A new approach to the management of chronic kidney disease
  • 2018 – Moin A Saleem (UK) – Stratified medicine in Nephrology